Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases

By Darson M.F.   Pacelli A.   Roche P.   Rittenhouse H.G.   Wolfert R.L.   Saeid M.S.   Young C.Y.F.   Klee G.G.   Tindall D.J.   Bostwick D.G.  

Urology, Vol. 53, Iss. 5, 1999-05 ,pp. : 939-944

Elsevier

Access to resources Recommend Favorite

Molecular Staging of Prostatic Cancer with RT-PCR Assay for Prostate-Specific Antigen in Peripheral Blood and Lymph Nodes: Comparison with Standard Histological Staging and Immunohistochemical Assessment of Occult Regional Lymph Node Metastases

By Martnez-Pineiro L.   Rios E.   Martnez-Gomariz M.   Pastor T.   de Cabo M.   Picazo M.L.   Palacios J.   Perona R.  

European Urology, Vol. 43, Iss. 4, 2003-04 ,pp. : 342-350

Elsevier

Access to resources Recommend Favorite

Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma

By El-Galley R.E.S.   Petros J.A.   Sanders W.H.   Keane T.E.   Galloway N.T.M.   Cooner W.H.   Graham S.D.  

Urology, Vol. 46, Iss. 2, 1995-08 ,pp. : 200-204

Elsevier

Access to resources Recommend Favorite

Comparison of proliferating cell nuclear antigen immunostaining in lymph node metastases and primary prostate adenocarcinoma after neoadjuvant androgen deprivation therapy

By Minardi Daniele   Galosi Andrea   Giannulis Ioannis   Montironi Rodolfo   Polito Mario   Muzzonigro Giovanni  

Scandinavian Journal of Urology and Nephrology, Vol. 38, Iss. 1, 2004-02 ,pp. : 19-25

Informa Healthcare

Access to resources Recommend Favorite

Prostate-specific membrane antigen: present and future applications

By Chang S.S.   Gaudin P.B.   Reuter V.E.   Heston W.D.W.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 622-629

Elsevier

Access to resources Recommend Favorite